These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7869617)

  • 41. Antiarrhythmic drugs preferentially produce conduction block at the area of slow conduction in the re-entrant circuit of canine atrial flutter: comparative study of disopyramide, flecainide, and E-4031.
    Inoue H; Yamashita T; Usui M; Nozaki A; Sugimoto T
    Cardiovasc Res; 1991 Mar; 25(3):223-9. PubMed ID: 1903082
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of antiarrhythmic drugs on premature action potential duration in canine ventricular muscle fibers.
    Varro A; Saitoh H; Surawicz B
    J Cardiovasc Pharmacol; 1987 Oct; 10(4):407-14. PubMed ID: 2444793
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative studies on the pharmacological actions of antiarrhythmic drugs in isolated rate papillary muscle.
    Sugimoto J; Nagata M; Morita M
    Clin Exp Pharmacol Physiol; 1978; 5(1):17-21. PubMed ID: 639355
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Selective depression of conduction of premature action potentials in canine Purkinje fibres by class Ib antiarrhythmic drugs: comparison with Ia and Ic drugs.
    Pallandi RT; Campbell TJ
    Cardiovasc Res; 1988 Mar; 22(3):171-8. PubMed ID: 3167941
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Profile of coronary vasodilator and cardiac actions of bepridil revealed by use of isolated, blood-perfused heart preparations of the dog.
    Kawada M; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1983; 5(4):604-12. PubMed ID: 6193358
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Electrophysiological effects of GYKI-23 107, a new antiarrhythmic compound, in isolated rabbit and canine cardiac preparations.
    Varró A; Németh M; Rabloczky G; Papp JG; Szekeres L
    J Cardiovasc Pharmacol; 1988 Mar; 11(3):251-7. PubMed ID: 2452917
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiarrhythmic effects of combined application of class I antiarrhythmic drugs; addition of low-dose mexiletine-enhanced antiarrhythmic effects of disopyramide and aprindine in various-rate canine ventricular tachycardias.
    Awaji T; Hashimoto K
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):960-6. PubMed ID: 7687723
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inotropic versus chronotropic, dromotropic, and coronary vasodilator actions of DPI 201-106, a novel positive inotropic agent, in the dog heart.
    Takahashi K; Endoh M; Taira N
    J Cardiovasc Pharmacol; 1987 Apr; 9(4):451-60. PubMed ID: 2438508
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of antiarrhythmic drugs, stimulation frequency, and potassium-induced resting membrane potential changes on conduction velocity and dV/dtmax in guinea pig myocardium.
    Buchanan JW; Saito T; Gettes LS
    Circ Res; 1985 May; 56(5):696-703. PubMed ID: 3995697
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Profile of cardiac and coronary vasodilator effects of MS-857, a novel cardiotonic agent, assessed in isolated, blood-perfused heart preparations of the dog.
    Maruyama M; Kamiya J; Kobari T
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):777-82. PubMed ID: 2481193
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of antiarrhythmic drugs on the premature action potential duration in canine cardiac Purkinje fibers.
    Varro A; Elharrar V; Surawicz B
    J Pharmacol Exp Ther; 1985 May; 233(2):304-11. PubMed ID: 3999021
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronotropic and inotropic effects of kampo extracts in the canine isolated, blood-perfused heart preparations.
    Sugiyama A; Hashimoto K
    Jpn J Pharmacol; 1989 Oct; 51(2):239-46. PubMed ID: 2593381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship between use-dependent effects of antiarrhythmic drugs on conduction and Vmax in canine cardiac Purkinje fibers.
    Nattel S
    J Pharmacol Exp Ther; 1987 Apr; 241(1):282-8. PubMed ID: 3572790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Electrophysiological effects of Org 7797 in the closed-chest anaesthetized dog.
    Leboeuf J; Basiez M; Massingham R
    Br J Pharmacol; 1993 Sep; 110(1):23-8. PubMed ID: 8220882
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Investigation of electrophysiologic mechanisms for the antiarrhythmic actions of R 56865 in cardiac glycoside toxicity.
    Damiano BP; Stump GL; Yagel SK
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):415-28. PubMed ID: 1720842
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiovascular profile of Bay K 8644, a presumed calcium channel activator, in the dog.
    Wada Y; Satoh K; Taira N
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):382-7. PubMed ID: 2581147
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inotropic and anesthetic potencies of etomidate and thiopental in dogs.
    Kissin I; Motomura S; Aultman DF; Reves JG
    Anesth Analg; 1983 Nov; 62(11):961-5. PubMed ID: 6625216
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lacidipine, a new long-acting dihydropyridine calcium antagonist, has high vascular selectivity against all intracardiac variables.
    Motomura S; Wu ZJ; Hashimoto K
    Heart Vessels; 1993; 8(1):16-22. PubMed ID: 8454559
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Asocainol, a new antiarrhythmic drug with natrium- and calcium-antagonistic effects on ventricular myocardium.
    Späh F
    J Cardiovasc Pharmacol; 1984; 6(6):1027-35. PubMed ID: 6084758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.